@misc{https://doi.org/10.5281/zenodo.4384762,<br/><span class="tab"></span>
  doi = {10.5281/ZENODO.4384762},<br/><span class="tab"></span>
  url = {https://zenodo.org/record/4384762},<br/><span class="tab"></span>
  author = {Pinato,<br/><span class="tab"></span> David J and Kaneko,<br/><span class="tab"></span> Takahiro and Saeed,<br/><span class="tab"></span> Anwaar and Pressiani,<br/><span class="tab"></span> Tiziana and Kaseb,<br/><span class="tab"></span> Ahmed and {Yinghong Wang} and Szafron,<br/><span class="tab"></span> David and Jun,<br/><span class="tab"></span> Tomi and {Sirish Dharmapuri} and Naqash,<br/><span class="tab"></span> Abdul Rafeh and {Mahvish Muzaffar} and {Musharraf Navaid} and {Chieh-Ju Lee} and {Anushi Bulumulle} and Yu,<br/><span class="tab"></span> Bo and Paul,<br/><span class="tab"></span> Sonal and Nimkar,<br/><span class="tab"></span> Neil and Bettinger,<br/><span class="tab"></span> Dominik and Hildebrand,<br/><span class="tab"></span> Hannah and Abugabal,<br/><span class="tab"></span> Yehia I and Ang,<br/><span class="tab"></span> Celina and Marron,<br/><span class="tab"></span> Thomas U and {Uqba Khan} and Personeni,<br/><span class="tab"></span> Nicola and Rimassa,<br/><span class="tab"></span> Lorenza and {Yi-Hsiang Huang}},<br/><span class="tab"></span>
  keywords = {bilirubin,<br/><span class="tab"></span> biomarkers,<br/><span class="tab"></span> hepatocellular carcinoma,<br/><span class="tab"></span> immunotherapy,<br/><span class="tab"></span> survival},<br/><span class="tab"></span>
  title = {Dataset related to article "Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade"},<br/><span class="tab"></span>
  publisher = {Zenodo},<br/><span class="tab"></span>
  year = {2020},<br/><span class="tab"></span>
  copyright = {Restricted Access}
}